S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,298.38
▼ -982.01 (-1.21%)
--:--:--
NYSE · Live ET

INMB (INMB)

1.46-0.08 (-5.19%)USD · · delayed · updates about every minute

Key statistics

Previous close
1.54
Day range
1.45 – 1.53
52-week low
1.09
52-week high
2.60
Volume
—
Type
—
52-WEEK RANGE POSITION

INMB news

TradingViewINmune Bio Inc. Estimates – NASDAQ:INMB1d agoSeeking AlphaINmune Bio Is A High-Potential Opportunity, But Here's Why I'm Waiting (NASDAQ:INMB)1d agoThe Globe and MailINmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar2d agoYahoo Finance UKINMB Nov 2026 3.000 call (INMB261120C00003000) stock price, news, quote and history3d agoTradingViewINmune Bio Inc. (INMB) Targets UK MAA in Feb 2027, Approval Mid-20273d agoBenzingaINmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-20273d agoStock TitanUK approval could come about six weeks earlier, Inmune Bio (INMB) says of its revised Ebstrocel plan.3d agoStock TitanA treatment for children with a skin disease could gain UK approval about six weeks sooner.3d ago

Learn to invest

The Psychology of Money
Morgan Housel · Beginner
The Little Book of Common Sense Investing
John C. Bogle · Beginner
The Intelligent Investor
Benjamin Graham · Intermediate